Latest Growth hormone Stories

NES-ZIONA, Israel, March 20, 2012 /PRNewswire/ -- PROLOR Biotech, Inc. (NYSE Amex: PBTH), a company developing next generation biobetter therapeutic proteins, today announced initiation of a Phase II clinical trial of its long-acting CTP-modified version of human growth hormone (hGH-CTP) in children with growth hormone deficiency. The pediatric trial follows successful completion of a Phase II trial of hGH-CTP in growth hormone deficient adults, which demonstrated that hGH-CTP was...

An international research team may have found a way to block a second wave of death that can result from pneumonia treatment. Antibiotics are effective at killing pneumococcus – the cause of about 50 percent of pneumonias – but as it dies the bacterium releases potentially lethal toxins. Adding an agonist that mimics the action of growth hormone-releasing hormone – which ultimately enables growth – may stop that second wave, according to research published in the Proceedings of...

NES-ZIONA, Israel, Jan. 18, 2012 /PRNewswire/ -- PROLOR Biotech, Inc. (NYSE Amex: PBTH) today announced positive top-line results from a post-Phase II clinical study of its long-acting CTP-modified version of human growth hormone (hGH-CTP) in growth hormone deficient adults. The data show that two injections of hGH-CTP per month have the potential to replace 30 consecutive daily injections of currently marketed human growth hormone. "We believe that the findings from this...

In a new study presented today at the annual meeting of the Radiological Society of North America (RSNA), growth hormone replacement for six months was found to increase bone formation in abdominally obese women. "This is the first time that the effects of growth hormone on bone have been studied in obesity," said the study's lead author, Miriam A. Bredella, M.D., a radiologist at Massachusetts General Hospital and assistant professor of radiology at Harvard Medical School in Boston....

(Ivanhoe Newswire) – Cushing’s disease is a hormone disorder that causes many symptoms, such as high blood pressure, fat accumulation, osteoporosis and ultimately ending in death. It is caused by a tumor in the anterior pituitary gland that secretes excess amounts of adrenocorticotrophic hormone (ACTH). The only treatment is removal of the tumor, however, researchers have found a new treatment for these reoccurring tumors. Researchers, led by Shlomo Melmed, at Cedars-Sinai Medical...

Cushing disease is a hormone disorder that causes a diverse array of symptoms, including fat accumulation, high blood pressure, osteoporosis, muscle wasting, and ultimately death. It is caused by a tumor in the anterior pituitary gland that results in the secretion of excess amounts of adrenocorticotropic hormone (ACTH). Treatment options are essentially limited to surgical resection. However, tumors commonly recur, meaning that new treatment options are needed. A team of researchers, led by...

Growth Hormones Direct announces top 3 recommendations for maximizing homeopathic growth hormone treatment. Phoenix, AZ (PRWEB) October 28, 2011 Growth Hormones Direct announces top 3 recommendations for maximizing homeopathic Growth Hormone treatment. Individuals accessing homeopathic forms of HGH treatment through Growth Hormones Direct are often health conscious. They are often searching for a means of improving their general health. These health conscious individuals are often willing...

SAN DIEGO, Oct. 20, 2011 /PRNewswire/ -- HGH.com announces its plan to give away a 1 year supply of any of its HGH, Body Building, or Muscle Gaining supplements. Customers can choose which product they want a 1 year supply of. All they have to do is send in a video testimonial of their favorite product, or how HGH.com helped them achieve a successful weight gain, muscle gain, or weight loss campaign using their proprietary vitamin pills. HGH.com is known for its leading edge products in the...

Growth Hormones Direct announces its most popular non Growth Hormone release product: B Total Vitamin Sublingual Drops. Phoenix, AZ (PRWEB) October 15, 2011 Growth Hormones Direct announces its most popular non Growth Hormone release product: B Total Vitamin Sublingual Drops. The B Total drops are a great support for individuals undergoing homeopathic Growth Hormone treatment, but are prized on their own for many reasons. B Total Sublingual Drops offer the following benefits:...

NES-ZIONA, Israel, Oct. 3, 2011 /PRNewswire/ -- PROLOR Biotech, Inc. (NYSE Amex: PBTH) today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office (PTO) for a patent application covering the company's long-acting CTP-enhanced human growth hormone (hGH-CTP). Upon issuance, the new patent would provide PROLOR with additional intellectual property protection covering the production and manufacturing processes used for hGH-CTP. This new protection will...